Product Overview
Progesterone 300mg SR Tablet contains Micronized Progesterone 300 mg, a natural form of the female hormone progesterone. It is commonly used in progesterone deficiency-related conditions, luteal phase support, menstrual irregularities, and hormone replacement therapy under medical supervision. �
1mg +1
Composition
Each Sustained Release Tablet Contains:
Micronized Progesterone IP/BP – 300 mg
Excipients – q.s.
(Composition may vary according to regulatory approval and formulation.)
Mechanism of Action
Progesterone works by:
Binding with progesterone receptors in reproductive tissues
Converting the uterine lining from proliferative phase to secretory phase
Supporting endometrial preparation for implantation
Helping maintain hormonal balance during fertility treatment and pregnancy support �
Uses / Indications
Progesterone 300mg SR may be prescribed for:
✅ Luteal phase support
✅ Assisted reproductive technology (ART/IVF support)
✅ Progesterone deficiency
✅ Menstrual cycle regulation
✅ Hormone replacement therapy support
✅ Endometrial protection during estrogen therapy �
Why Choose Cordium Pharma?
Cordium Pharma – Your Trusted Pharmaceutical Partner
✔ High-quality pharmaceutical manufacturing standards
✔ Focus on Women’s Health & Fertility Segment
✔ Reliable supply chain for international markets
✔ Documentation support for export requirements
✔ Quality-focused production approach
✔ Customized packaging solutions for global markets
European Market Reference Brands
Some progesterone 300 mg products available in European markets include:
Utrogestan 300 mg – widely recognized micronized progesterone brand in Europe �
Eurogest 300mg Tablet SR �
1mg
(Cordium Pharma products are positioned as quality alternatives according to applicable regulatory requirements.)
Export Focus Markets
High potential markets for progesterone products:
🇪🇺 Europe
Germany
Spain
Italy
UK
France
🌍 Other Fertility Markets:
UAE
South Africa
Southeast Asia
Contact Cordium Pharma
Cordium Pharma
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
